The PI3K-Akt signaling pathway has been shown to regulate Brn-2 expression in melanoma cells [29,36], and integrin α3β1 has been shown to activate this pathway in epithelial cells and cancer cells, including breast cancer cells [15,16,37,38]. The gene discussed is AKT1; the disease is breast cancer.